Quantitative Systematic Strategies LLC Amarin Corp Plcuk Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	BUY	$5.03 - $8.8 $223,115 - $390,341	44,357 Added 396.08%	55,556 $345,000
Q4 2020 Feb 09, 2021	SELL	$4.04 - $5.31 $72,954 - $95,887	-18,058 Reduced 61.72%	11,199 $55,000
Q3 2020 Nov 09, 2020	SELL	$3.64 - $7.76 $41,077 - $87,571	-11,285 Reduced 27.84%	29,257 $123,000
Q2 2020 Aug 04, 2020	BUY	$4.78 - $8.26 $120,594 - $208,391	25,229 Added 164.76%	40,542 $281,000
Q1 2020 May 06, 2020	BUY	$4.0 - $21.53 $61,252 - $329,688	15,313 New	15,313 $61,000
Q4 2018 Feb 12, 2019	SELL	$12.41 - $22.98 $153,586 - $284,400	-12,376 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $30,321 - $201,357	12,376 New	12,376 $201,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.